BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21755284)

  • 1. Case Report: Long-Term Survival in Patients with Initial Lung-Only Metastasis from Pancreatic Adenocarcinoma.
    Gotfried JI; Kozuch PS
    J Gastrointest Cancer; 2012 Sep; 43 Suppl 1():S50-5. PubMed ID: 21755284
    [No Abstract]   [Full Text] [Related]  

  • 2. The indolent nature of pulmonary metastases from ductal adenocarcinoma of the pancreas.
    Downs-Canner S; Zenati M; Boone BA; Varley PR; Steve J; Hogg ME; Zureikat A; Zeh HJ; Lee KK
    J Surg Oncol; 2015 Jul; 112(1):80-5. PubMed ID: 26153355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of pathologic response to preoperative therapy in pancreatic cancer.
    Chun YS; Cooper HS; Cohen SJ; Konski A; Burtness B; Denlinger CS; Astsaturov I; Hall MJ; Hoffman JP
    Ann Surg Oncol; 2011 Dec; 18(13):3601-7. PubMed ID: 21947697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combined treatment of lung cancer].
    Trakhtenberg AKh; Kiseleva ES; Kharchenko VP; Zakharchenkov AV; Barchuk AS
    Vopr Onkol; 1987; 33(10):25-30. PubMed ID: 3686904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An aggressive therapeutic approach to carcinoma of the body and tail of the pancreas.
    Ozaki H; Kinoshita T; Kosuge T; Yamamoto J; Shimada K; Inoue K; Koyama Y; Mukai K
    Cancer; 1996 Jun; 77(11):2240-5. PubMed ID: 8635090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Borderline and locally advanced pancreatic adenocarcinoma margin accentuation with intraoperative irreversible electroporation.
    Kwon D; McFarland K; Velanovich V; Martin RC
    Surgery; 2014 Oct; 156(4):910-20. PubMed ID: 25239345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An autopsy report of pancreatic carcinoma following the achievement of significant prolongation of survival, despite the lack of a definitive diagnosis].
    Tajiri H; Kitahara T; Yoshimori M; Nakamura K; Hijikata A; Ozaki H
    Gan No Rinsho; 1984 Mar; 30(3):307-10. PubMed ID: 6425536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in Treatment and Outcome of Pancreatic Adenocarcinoma Stage I and II in the EURECCA Pancreas Consortium.
    Groen JV; Sibinga Mulder BG; van Eycken E; Valerianova Z; Borras JM; van der Geest LGM; Capretti G; Schlesinger-Raab A; Primic-Zakelj M; Ryzhov A; van de Velde CJH; Bonsing BA; Bastiaannet E; Mieog JSD
    Ann Surg Oncol; 2018 Nov; 25(12):3492-3501. PubMed ID: 30151560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Resection of pancreatic cancer and simultaneous lung metastasis--a case report of successful in tumor dormancy mainly by postoperative 5-fluorouracil-based chemotherapy].
    Baba H; Goseki N; Takamatsu S; Nosaka T; Teramoto K; Arii S; Kumagai J
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2382-5. PubMed ID: 12484080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival after trimodality treatment for superior sulcus and central T4 non-small cell lung cancer.
    De Leyn P; Vansteenkiste J; Lievens Y; Van Raemdonck D; Nafteux P; Decker G; Coosemans W; Decaluwé H; Moons J; Lerut T
    J Thorac Oncol; 2009 Jan; 4(1):62-8. PubMed ID: 19096308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of resection margin status and postoperative CA19-9 levels on survival and patterns of recurrence after postoperative high-dose radiotherapy with 5-FU-based concurrent chemotherapy for resectable pancreatic cancer.
    Kinsella TJ; Seo Y; Willis J; Stellato TA; Siegel CT; Harpp D; Willson JK; Gibbons J; Sanabria JR; Hardacre JM; Schulak JP
    Am J Clin Oncol; 2008 Oct; 31(5):446-53. PubMed ID: 18838880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of clinical status on survival in patients with borderline or locally advanced pancreatic adenocarcinoma.
    Duconseil P; Garnier J; Weets V; Ewald J; Marchese U; Gilabert M; Moureau-Zabotto L; Poizat F; Giovannini M; Delpero JR; Turrini O
    World J Surg Oncol; 2019 Jun; 17(1):95. PubMed ID: 31164144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival.
    Rose JB; Rocha FG; Alseidi A; Biehl T; Moonka R; Ryan JA; Lin B; Picozzi V; Helton S
    Ann Surg Oncol; 2014 May; 21(5):1530-7. PubMed ID: 24473642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative mortality following multi-modality therapy for pancreatic cancer: Analysis of the SEER-Medicare data.
    Nayar P; Chandak A; Gupta N; Yu F; Qiu F; Ganti AK; Are C
    J Surg Oncol; 2017 Feb; 115(2):158-163. PubMed ID: 28133817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant therapy for resectable pancreatic cancer.
    Raut CP; Evans DB; Crane CH; Pisters PW; Wolff RA
    Surg Oncol Clin N Am; 2004 Oct; 13(4):639-61, ix. PubMed ID: 15350939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
    Schnelldorfer T; Ware AL; Sarr MG; Smyrk TC; Zhang L; Qin R; Gullerud RE; Donohue JH; Nagorney DM; Farnell MB
    Ann Surg; 2008 Mar; 247(3):456-62. PubMed ID: 18376190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential and/or concurrent hypofractionated radiotherapy and concurrent chemotherapy in neoadjuvant treatment of advanced adenocarcinoma of the pancreas. Outcome and patterns of failure.
    Zimmermann FB; Schuhmacher C; Lersch C; Bernhardt B; Pickel P; Siewert JR; Molls M; Jeremic B
    Hepatogastroenterology; 2004; 51(60):1842-6. PubMed ID: 15532839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic pulmonary adenocarcinoma 13 years after curative resection for pancreatic cancer: report of a case and review of Japanese literature.
    Kitasato Y; Nakayama M; Akasu G; Yoshitomi M; Mikagi K; Maruyama Y; Kawahara R; Ishikawa H; Hisaka T; Yasunaga M; Horiuchi H; Saito N; Takamori S; Okabe Y; Kage M; Kinoshita H; Tanaka H
    JOP; 2012 May; 13(3):296-300. PubMed ID: 22572136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New frontiers in the neoadjuvant therapy of pancreatic adenocarcinoma: apart from therapeutical protocols.
    Berardi R; Verdecchia L; Scartozzi M; Cascinu S
    JOP; 2005 Jan; 6(1 Suppl):118-21. PubMed ID: 15650296
    [No Abstract]   [Full Text] [Related]  

  • 20. A case of metastatic pancreatic adenocarcinoma with prolonged survival after combination of neoadjuvant FOLFIRINOX therapy and synchronous distal pancreatectomy and hepatectomy.
    Neofytou K; Giakoustidis A; Smyth EC; Cunningham D; Mudan S
    J Surg Oncol; 2015 May; 111(6):768-70. PubMed ID: 25556724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.